Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 3 9Phase 4 6Phase 2/3 4Phase 1/2 3Phase 1 2Phase NA 1

Status

Unknown 6Completed 3

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Plasma cell 3Tumor-Agnostic 1Thoracic 1Gastrointestinal 1

Conditions

Multiple Myeloma 2Stomach Neoplasms 1Neoplasms, Second Primary 1Neoplasms 1NSCLC 1Immunoglobulin Light-chain Amyloidosis 1

Interventions

Metformin 16Cyclophosphamide 15Drug Therapy 14Dexamethasone 14Cisplatin 14Cytarabine 11Gemcitabine 10Radiotherapy 9Carboplatin 9Vincristine 8Paclitaxel 8Oxaliplatin 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Thalidomide × Clear all
NCT04612582 2020-11-03

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Guangdong Provincial People's Hospital

Phase 4 Unknown
70 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT03777930 2018-12-19

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Shenzhen Fifth People's Hospital

Phase 4 Unknown
200 enrolled
Tumor-Agnostic

Neoplasms, Neoplasms, Second Primary

NCT02559154 2018-05-04

Modified Bortezomib-based Combination Therapy for Multiple Myeloma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 4 Unknown
80 enrolled
Plasma cell

Multiple Myeloma

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Henan Provincial People's Hospital

Phase 4 Unknown
67 enrolled
Thoracic

NSCLC

NCT02401971 2015-03-30

ITAGC

Zhengzhou University

Phase 4 Unknown
900 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01249690 2010-11-30

Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma

Second Military Medical University

Phase 4 Unknown
100 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡